Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  42.00 3.39% 1,282.00 1,272.00 1,284.00 1,284.00 1,230.00 1,230.00 160,884 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.3 0.7 1.0 1,282.0 506

Biotech Growth Share Discussion Threads

Showing 1 to 18 of 325 messages
Chat Pages: Latest  1
DateSubjectAuthorDiscuss
20/4/2012
09:20
This trust looks interesting anyone know much about it ?
nw99
03/4/2012
09:34
Yes, see Trust Net. I have now sold fwiw.
philo124
02/4/2012
20:28
Private investors will be looking into buying into this as it appears as a top performer over 3 years in quite a few publications
4wingrove
19/3/2012
15:54
Nice Chart eh?
philo124
01/2/2012
20:33
This is doing really well recently anybody can shed any light as to why
4wingrove
04/6/2011
15:55
Unfortunately that is often what you get for being in the game early on. Things are changing and the sector will become like the Internet after the 2001 bubble/rubble was cleared up. There is serious money to be made and it's too risky to hold single shares if you are an average Jo. The best access is via a fund. It's worth another look now - when I get enough free time.
timtom2
11/4/2011
22:22
It's approaching the price (share wise) that it was a decade ago. Enough - unfortunately - said...
damanko
10/4/2011
21:52
This stick s.in my mind and Deutsche have lightened up - http://www.thebusinessdesk.com/westmidlands/biotech-growth-trust-underperforms.html
timtom2
30/9/2010
14:08
I hold some shares in BIOG rather by accident. I thought I had sold all my old Finsbury shares but it turns out I didn't. I do not see this as being a long term holding and anticipate selling sometime in the next 12 months. I am tempted to do so now as it has had a decent run. Any views as to whether I should hold on for a while?
alan russell
21/7/2010
18:33
Latest from Edison - The Biotech Growth Trust Plc (BIOG) has put in a respectable performance during the past 12 months, outperforming its benchmark, the NASDAQ Biotechnology Index (sterling adjusted), by 2.8% in terms of NAV total return and 3.9% in terms of share price total return. The manager believes that concerns over US healthcare reform were overdone and, while this cloud of uncertainty has lifted, concerns regarding the outlook in Europe have delayed the reversion. Looking forward, the manager considers that; biotech will be a net beneficiary of healthcare reform; the regulatory environment will continue to improve; M
chingman
15/4/2010
18:50
Performance of IBT does not match BIOG certainly over last year which probably accounts for their discount to NAV
4wingrove
15/4/2010
10:12
IBT is cheaper at 18% below asset value.
davebowler
05/2/2010
19:01
Tipped in this weeks Moneyweek their argument for biotech looks tempting might buy some through III on a monthly basis through portfolio builder
4wingrove
26/1/2010
19:28
Ian - two is a crowd ............... I didn't bother participating in the recent fund raising, as the amount payable (ie the stated NAV) was some way north of the share price. In fact, I meant to write to the board, and ask who on earth would bother (amongst longer term holders) - when this was the case. Whatever, the institutions were keen, and the price has carried on its mild upward trend. Worth tucking away. Mind you, having bought about nine years ago, I'm now only 25% or so down on what I paid. Ho hum....
damanko
25/1/2010
10:04
damanko - sorry to spoil your solitude!! recommendation on CityWire this morning Why Biotech Growth Trust is the pick of the sector http://www.citywire.co.uk/professional/-/news/investment-trusts/content.aspx?ID=378464
ianbrewster
17/11/2009
00:11
I expect no more than a handful of people to look at this. Perhaps IT followers, which will do quite nicely. They will be aware of the difference between Unit & Investment Trusts. Performance wise. Over time. This little IT has gone from star, to basket case - to a decent punt on the biotech industry, over the past decade.
damanko
16/11/2009
21:08
Placing & offer for subscription announced today.
damanko
16/11/2009
19:54
See graphs above. By the standards of 2008 / 2009, this little Investment Trust has had a reasonably decent year, main investments as under: Celgene United States Amgen United States Gilead Sciences United States Genzyme United States Curis * United States Dendreon United States Biogen Idec United States Vertex US Alexion US Cephalon United States Top 10 Investments $46,237 59.7%
damanko
Chat Pages: Latest  1
ADVFN Advertorial
Your Recent History
LSE
BIOG
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200808 12:48:14